Related Experiment Video
Updated: May 24, 2026

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
Published on: November 11, 2014
FUS-related proteinopathies: lessons from animal models
Nicholas A Lanson1, Udai Bhan Pandey
1Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA 70112-2223, USA.
Abstract:
The recent identification of ALS-linked mutations in FUS and TDP-43 has led to a major shift in our thinking in regard to the potential molecular mechanisms of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). RNA-mediated proteinopathy is increasingly being recognized as a potential cause of neurodegenerative disorders. FUS and TDP-43 are structurally and functionally similar proteins. FUS is a DNA/RNA binding protein that may regulate aspects of RNA metabolism, including splicing, mRNA processing, and micro RNA biogenesis. It is unclear how ALS-linked mutations perturb the functions of FUS. This review highlights recent advances in understanding the functions of FUS and discusses findings from FUS animal models that provide several key insights into understanding the molecular mechanisms that might contribute to ALS pathogenesis.
Insights
Mutations in FUS and TDP-43 are linked to neurodegenerative diseases like ALS and FTLD. This review explores how FUS protein dysfunction, particularly RNA-mediated effects, contributes to these conditions.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are linked to mutations in FUS and TDP-43.
- RNA-mediated proteinopathy is an emerging mechanism in neurodegenerative disorders.
- FUS and TDP-43 are structurally and functionally similar DNA/RNA binding proteins.
Purpose of the Study:
- To review recent advances in understanding FUS protein functions.
- To discuss insights from FUS animal models regarding ALS pathogenesis.
- To explore how ALS-linked mutations affect FUS functions.
Main Methods:
- Literature review of FUS functions and related research.
- Analysis of findings from FUS animal models.
- Discussion of molecular mechanisms in ALS pathogenesis.
Main Results:
- FUS plays a role in RNA metabolism, including splicing and microRNA biogenesis.
- ALS-linked mutations are suspected to perturb normal FUS functions.
- FUS animal models offer key insights into disease mechanisms.
Conclusions:
- Understanding FUS protein function is crucial for elucidating ALS pathogenesis.
- RNA-mediated mechanisms are increasingly recognized in neurodegeneration.
- Further research into FUS dysfunction may reveal therapeutic targets for ALS and FTLD.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

